-
Efgartigimod alfa, sold
under the
brand name Vyvgart, is a
medication used to
treat myasthenia gravis.
Efgartigimod alfa is a
neonatal Fc
receptor blocker...
-
Efgartigimod alfa/hyaluronidase, sold
under the
brand name
Vyvgart Hytrulo, is a
coformulation medication used for the
treatment of
generalized myasthenia...
-
carefully selected cases.
Efgartigimod alfa (Vyvgart) was
approved for
medical use in the
United States in
December 2021.
Efgartigimod alfa/hyaluronidase (Vyvgart...
-
prior line of
therapy including lenalidomide and a
proteasome inhibitor.
Efgartigimod alfa/hyaluronidase (Vyvgart Hytrulo) was
approved for the
treatment of...
- and skin
blistering diseases (pemphigus), and the Fc-based inhibitor,
efgartigimod,
based on the 'Abdeg'
technology was
recently approved (as 'Vyvgart')...
-
Apremilast L04AA40
Cladribine L04AA41
Imlifidase L04AA48
Belumosudil L04AA58
Efgartigimod alfa L04AB01
Etanercept L04AB02
Infliximab L04AB03
Afelimomab L04AB04...
-
Deucravacitinib Deuruxolitinib Dimethyl fumarate Diroximel fumarate Efgartigimod alfa (+hyaluronidase)
Etrasimod Filgotinib Fingolimod Guselkumab Iptacopan...
- a biobank. As of May 2023,
Metrodora is parti****ting in a
trial of
efgartigimod for POTS. Aspan,
Maria (October 4, 2021). "Why Instacart's new CEO is...
-
Deucravacitinib Deuruxolitinib Dimethyl fumarate Diroximel fumarate Efgartigimod alfa (+hyaluronidase)
Etrasimod Filgotinib Fingolimod Guselkumab Iptacopan...
